Showing results (91-100 of 298) with videos related to
Sort By:
Pageof 30
Alzheimer'S Research & Therapy|June 6, 2020
Immediate and long-term consequences of COVID-19 infections for the development of neurological diseaseMichael T Heneka, Douglas Golenbock, Eicke Latz, et al.Nature Reviews. Neurology|September 15, 2021
Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectusBrianne M Bettcher, Malú G Tansey, Guillaume Dorothée, et al.Neurobiology of Disease|July 20, 2002
Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cellsMaría Antonia Baltrons, Carlos E Pedraza, Michael T Heneka, et al.Journal of Neurology|July 24, 2012
Long-term neuromuscular sequelae of critical illnessAlexander Semmler, Torsten Okulla, Markus Kaiser, et al.Plos One|February 9, 2013
Clinical symptoms and risk factors in cerebral microangiopathy patientsSandra Okroglic, Catherine N Widmann, Horst Urbach, et al.Experimental Gerontology|June 14, 2022
Falls at advanced age - The importance to search for benign paroxysmal positional vertigo (BPPV)Jasmin Krieger, Monika Frackowiak, Moritz Berger, et al.Journal of Neurochemistry|December 24, 2003
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activationThomas Dehmer, Michael T Heneka, Magdalena Sastre, et al.Journal of Chemical Neuroanatomy|August 27, 2005
Systemic inflammation induces apoptosis with variable vulnerability of different brain regionsAlexander Semmler, Torsten Okulla, Magdalena Sastre, et al.Nature|January 3, 2018
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's diseaseCarmen Venegas, Sathish Kumar, Bernardo S Franklin, et al.Journal of Neuroinflammation|June 17, 2014
CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous systemMarius Krauthausen, Simon Saxe, Julian Zimmermann, et al.Pageof 30